TSUJIKAWA Tetsuya

FacultyBiomedical Imaging Research Center
Teacher OrganizationBiomedical Imaging Research Center
Education and
 Research Organization
Biomedical Imaging Research Center
PositionAssociate Professor
Last Updated: 19/12/05 16:14

Researcher Profile & Settings

Name

    TSUJIKAWA Tetsuya

Affiliation

  •  Biomedical Imaging Research Center Associate Professor

Academic & Professional Experience

  • Apr. 2006Biomedical Imaging Research Center, University of Fukui assistant
  • Apr. 2004Mar. 2006Department of Radiology, The University of Tokushima Graduate School assistant

Association Memberships

    Japan Radiological Society member,Japanese Society of Nuclear Medicine member,Japanese Society for Therapeutic Radiology and Oncology member,The Japanese College of Radiology member,

Research Activities

Published Papers

  • Comparison of two PET radioligands, [11C]FPEB and [11C]SP203, for quantification of metabotropic glutamate receptor 5 in human brain
    Lohith TG, Tsujikawa T, Simeon FG, Veronese M, Zoghbi SS, Lyoo CH, Kimura Y, Morse CL, Pike VW, Fujita M, Innis RB
    J Cereb Blood Flow Metab Jan.  2016 Refereed
  • Present and future roles of FDG-PET/CT imaging in the management of lung cancer.
    Kitajima K, Doi H, Kanda T, Yamane T, Tsujikawa T, Kaida H, Tamaki Y, Kuribayashi K.
    Jpn J Radiol 34(6) 387-399 Jun.  2016 Refereed
  • Different prognostic implications of 18F-FDG PET between histological subtypes in patients with cervical cancer
    T.Rahman, T.Tsujikawa, M.Yamamoto, Y.Chino, A.Shinagawa, T.Kurokawa, T.Tsuchida, H.Kimura, Y.Yoshida, H.Okazawa
    Medicine (Baltimore) 95(9) e3017 Mar.  2016 Refereed
  • Prognostic value of dual-time-point 18F-FDG PET for idiopathic pulmonary fibrosis.
    Y.Umeda, Y.Demura, M.Morikawa, M.Anzai, M.Kadowaki, S.Ameshima, T.Tsuchida, T.Tsujikawa, Y.Kiyono, H.Okazawa, T.Ishizaki, T.Ishizuka
    J Nucl Med. 56(12) 1869-1875 Dec.  2015 Refereed
  • Comparison of image quality with 62Cu and 64Cu-labeled radiotracers in positron emission tomography whole-body phantom imaging.
    M.Kobayashi, T.Mori, T.Tsujikawa, K.Ogai, J.Sugama, Y.Kiyono, K.Kawai, H.Okazawa
    Hell J Nucl Med 18(2) 103-107 May  2015 Refereed
  • Assessing Tumor Hypoxia in Head and Neck Cancer by PET With 62Cu-Diacetyl-Bis(N4-Methylthiosemicarbazone)
    Y.Sato, T.Tsujikawa, M.Oh, T.Mori, Y.Kiyono, S.Fujieda, H.Kimura, H.Okazawa
    Clin Nucl Med 39(12) 1027-1032 Dec.  2014 Refereed
  • Evaluation in Monkey of Two Candidate PET Radioligands, [11C]RX-1 and [18F]RX-2, for Imaging Brain 5-HT4 Receptors
    Lohith TG, Xu R, Tsujikawa T, Morse CL, Anderson KB, Gladding RL, Zoghbi SS, Fujita M, Innis RB, Pike VW.
    Synapse Refereed
  • Brain imaging for oxidative stress and mitochondrial dysfunction in neurodegenerative disease
    H.Okazawa, M.Ikawa, T.Tsujikawa, Y.Kiyono, M.Yoneda
     58(4) 387-397 Dec.  2014 Refereed
  • In vitro and in vivo evaluation of 11C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors
    Tsujikawa T, Zoghbi SS, Hong J, Donohue SR, Jenko KJ, Gladding RL, Halldin C, Pike VW, Innis RB, Fujita M
    NeuroImage 84 733-741 Jan.  2014 Refereed
  • Detection of preclinically latent hyperperfusion due to stroke-like episodes by arterial spin-labeling perfusion MRI in MELAS patients
    M.Ikawa, M.Yoneda, T.Muramatsu, A.Matsunaga, T.Tsujikawa, T.Yamamoto, N.Kosaka, K.Kinoshita, O.Yamamura, T.Hamano, Y.Nakamoto, H.Kimura
     13(6) 676-680 Nov.  2013 Refereed
  • Oestrogen-related tumour phenotype: PET characterisation with 18F-FDG and 18F-FES
    T.Tsujikawa, Y.Yoshida, H.Maeda, T.Tsuchida, T.Mori, Y.Kiyono, H.Kimura, H.Okazawa
     85(1015) 1020-1024 Jun.  2012 Refereed
  • Appropriate parameters of ordered-subset expectation maximization algorithm on measurement of myocardial blood flow and oxygen consumption with 11C-acetate PET
    M.Kobayashi, T.Mori, Y.Kiyono, T.Tsujikawa, R.Maruyama, Y.Higaki, N.Shikano, R.Nishii, K.Kawai, T.Kudo, H.Okazawa
     33(2) 130-138 Feb.  2012 Refereed
  • Crossed cerebellar hyperperfusion after MELAS attack followed up by whole brain continuous arterial spin labeling perfusion imaging
    T.Tsujikawa, T.Yamamoto, M.Ikawa, M.Yoneda, H.Kimura
     53(2) 220-222 Dec.  2011 Refereed
  • Role of PET/CT in gynecological tumors based on the revised FIGO staging classification
    T.Tsujikawa, T.Tsuchida, Y.Yoshida, T.Kurokawa, Y.Kiyono, H.Okazawa, H.Kimura
     36(9) e114-118 Sep.  2011 Refereed
  • Differentiation of histological subtypes in lung cancer with 18F-FDG-PET 3-point imaging and kinetic analysis
    T. Tsuchida, Y. Demura, M. Sasaki, M. Morikawa, Y. Umeda, T. Tsujikawa, T. Kudoh, H. Okazawa, H. Kimura
    Hell J Nucl Med 14(3) 224-7 Sep.  2011 Refereed
  • Kikuchi-Fujimoto disease; PET/CT assessment of a rare cause of cervical lymphadenopathy
    T.Tsujikawa, T.Tsuchida, Y.Imamura, M.Kobayashi, S.Asahi, K.Shimizu, K.Tsuji, Y.Kiyono, H.Okazawa, H.Kimura
     36(8) 661-664 Aug.  2011 Refereed
  • Functional oestrogen receptor alpha imaging in endometrial carcinoma using 16α-[18F]fluoro-17β-oestradiol PET
    T.Tsujikawa, Y.Yoshida, Y.Kiyono, T.Kurokawa, T.Kudo, Y.Fujibayashi, F.Kotsuji, H.Okazawa
     38(1) 37-45 Jan.  2011 Refereed
  • Additional value of 16α-[18F]fluoro-17β-estradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET
    Y.Yoshida, Y.Kiyono, T.Tsujikawa, T.Kurokawa, H.Okazawa, F.Kotsuji
     38(10) 1824-1831 Jan.  2011 Refereed
  • Embolic infarction followed by serial bone SPECT and MR fusion images-the door to SPECT/MR
    T. Tsujikawa, T. Kamibayashi, T. Tsuchida, Y. Ohkoshi, H. Kimura
     57(3,4) 334-337 Aug.  2010 Refereed
  • Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images
    T. Tsujikawa, M. Yoneda, Y. Shimizu, H. Uematsu, M. Toyooka, M. Ikawa, T. Kudo, H. Okazawa, M. Kuriyama, H. Kimura
     32(2) 143-149 Feb.  2010 Refereed
  • Validation of calculating the clearance rate constant (kmono) of [11C]acetate using parametric kmono image for myocardial oxidative metabolism
    R.Hussain, T.Kudo, T.Tsujikawa, M.Kobayashi, Y.Fujibayashi, H.Okazawa
     36(8) 877-882 Nov.  2009 Refereed
  • Assessment of fluorodeoxyglucose uptake by leiomyomas in relation to histopathologic subtype and the menstrual state
    Y.Yoshida, T.Tsujikawa, T.Kurokawa, T.Tsuji, Y.Imamura, Y.Fujibayashi, H.Okazawa, F.Kotsuji
    J Comput Assist Tomogr 33(6) 877-881 Nov.  2009 Refereed
  • Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16alpha-18F-fluoro-17beta-estradiol PET
    Y.Yoshida, T.Kurokawa, T.Tsujikawa, H.Okazawa, F.Kotsuji
    Journal of Ovarian Research 2(1) 7 Jun.  2009 Refereed
  • Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl-CoA/acetate metabolism
    Y.Yoshii, T.Furukawa, H.Yoshii, T.Mori, Y.Kiyono, A.Waki, M.Kobayashi, T.Tsujikawa, T.Kudo, H.Okazawa, Y.Fujibayashi
     100(5) 821-827 May  2009 Refereed
  • Functional images reflect aggressiveness of endometrial carcinoma: Estrogen receptor expression combined with FDG-PET
    T.Tsujikawa, Y.Yoshida, T.Kudo, Y.Kiyono, T.Kurokawa, M.Kobayashi, T.Tsuchida, Y.Fujibayashi, F.Kotsuji, H.Okazawa
    J Nucl Med 50(10) 1598-1604 Jan.  2009 Refereed
  • Vasodilatory effect of adenosine triphosphate does not change cerebral blood flow - A PET study with 15O-water
    R.Hussain, T.Tsuchida, T.Kudo, M.Kobayashi, T.Tsujikawa, Y.Kiyono, Y.Fujibayashi, H.Okazawa
     23(8) 717-723 Jan.  2009 Refereed
  • Uterine tumors: Pathophysiologic imaging with 16α-[18F]fluoro-17β-estradiol and FDG-PET ? Initial experience
    T.Tsujikawa, Y.Yoshida, T.Mori, T.Kurokawa, Y.Fujibayashi, F.Kotsuji, H.Okazawa
    Radiology 248(2) 599-605 Aug.  2008 Refereed
  • Reproducibility of Semi-quantitative Parameters in FDG-PET Using Two Different PET Scanners: Influence of Attenuation Correction Method and Examination Interval
    T.Kamibayashi, T.Tsuchida, Y.Demura, T.Tsujikawa, H.Okazawa, T.Kudo, H.Kimura
    Mol Imaging Biol. 10(3) 162-166 May  2008 Refereed
  • Comparison of 18F-FDG PET and MRI in assessment of uterine smooth muscle tumors
    Y.Yoshida, T.Kurokawa, Y.Sawamura, A.Shinagawa, T.Tsujikawa, H.Okazawa, T.Tsuchida, Y.Imamura, N.Suganuma, F.Kotsuji
    J Nucl Med 49(5) 708-712 May  2008 Refereed
  • Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET
    T.Tsuchida, H.Takeuchi, H.Okazawa, T.Tsujikawa, Y.Fujibayashi
    Nucl Med Biol 35(2) 171-176 Feb.  2008 Refereed
  • Distinctive FDG and FES accumulation pattern of two tamoxifen treated patients with endometrial hyperplasia
    T.Tsujikawa, H.Okazawa, Y.Yoshida, T.Mori, M.Kobayashi, T.Tsuchida, Y.Fujibayashi
    Ann Nucl Med 22(1) 73-77 Jan.  2008 Refereed
  • Does partial volume corrected maximum SUV based on count recovery coefficient in 3D-PET/CT correlate with clinical aggressiveness of non-Hodgkin lymphoma?
    T.Tsujikawa, H.Otsuka, N.Morita, H.Saegusa, M.Kobayashi, H.Okazawa, H.Nishitani
    Ann Nucl Med 22(1) 23-30 Jan.  2008 Refereed
  • Post-processing technique with MDCT data improves the accuracy of the detection of lung nodules
    K.Yoneda, J.Ueno, S.Nishihara, T.Tsujikawa, N.Morita, H.Otsuka, K.Furutani, H.Nishitani, K.Kondo, Y.Nishioka
     25(10) 511-515 Dec.  2007 Refereed
  • A 18F-FDG-positive, 67Ga-negative, and transferrin receptor expression-negative patient with diffuse large B-cell lymphoma
    T.Tsujikawa, H.Okazawa, T.Tsuchida, Y.Demura, Y.Imamura, Y.Fujibayashi
    Ann Nucl Med 21(6) 375-378 Aug.  2007 Refereed
  • Accurate estimation of regional and global cardiac function in old myocardial infarction patients by multidetector-row computed tomography
    K.Yamaguchi, M.Nomura, T.Tsujikawa, K.Koshiba, S.Ito
     54(42067) 72-82 Feb.  2007 Refereed
  • Risk factors associated with soft coronary artery plaques in Japanese, as determined by 16 slice multidetector-row computed tomography
    Tetsuya Tsujikawa, Masahiro Nomura, Kimiko Nakayasu, Tomohito Kawano, Yutaka Nakaya, Susumu Ito, Hiromu Nishitani
    The Journal of Medical Investigation 53(3,4) 310-316 Aug.  2006 Refereed
  • Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5
    Yaichiro Hashimoto, Tetsuya Tsujikawa, Chisato Kondo, Masako Maki, Mitsuru Momose, Atsushi Nagai, Takamasa Ohnuki, Tishio Nishikawa, Kiyoko Kusakabe
    The Journal of Nuclear Medicine 47(3) 426-431 Mar.  2006 Refereed
  • 123I-metaiodo-benzylguanidine myocardial scintigraphy in the Brugada-type ECG
    Takashi Kawaguchi, Masahiro Nomura, Tetsuya Tsujikawa, Yutaka Nakaya, Susumu Ito
    The Journal of Medical Investigation 53(1,2) 95-102 Feb.  2006 Refereed
  • Two cases of retroperitoneal hematoma caused by combination of anticoagulant therapy and 5-fluorouracil
    Naomi Morita, Kennichi Kashihara, Hiroshi Tagashira, Hideki Otsuka, Kazuhide Yoneda, Tomoya Murase, Tetsuya Tsujikawa, Syunnsuke Furutani, Kaori Furutani, Masako Minato, Hiromu Nishitani
    The Journal of Medical Investigation 52(1,2) 114-117 Feb.  2005 Refereed
  • Three-dimensional imaging of thoracic diseases with multidetector row CT
    Junji Ueno, Tomoya Murase, Kazuhide Yoneda, Tetsuya Tsujikawa, Shoji Sakiyama, Kazuya Kondoh
    The Journal of Medical Investigation 51(3,4) 163-170 Aug.  2004 Refereed
  • Metabolic tumor burden predicts prognosis of ovarian cancer patients who receive platinum-based adjuvant chemotherapy.
    Yamamoto M, Tsujikawa T, Fujita Y, Chino Y, Kurokawa T, Kiyono Y, Okazawa H, Yoshida Y
    Cancer Sci 107(4) 478-485 Apr.  2016 Refereed
  • Arterial transit time mapping obtained by pulsed continuous 3D ASL imaging with multiple post-label delay acquisitions: Comparative study with PET-CBF in patients with chronic occlusive cerebrovascular disease.
    Tsujikawa T, Kimura H, Matsuda T, Fujiwara Y, Isozaki M, Kikuta K, Okazawa H.
    PLoS ONE 11(6) e0156005 Jun.  2016 Refereed
  • Impact on PET texture features of imaging biomarkers for predicting survival of patients with uterine sarcoma-preliminary results.
    M.Yamamoto, T.Tsujikawa, H.Okazawa, Y.Yoshida
    Biomarker J 2(1) e3017 Mar.  2016 Refereed
  • Assessment of the tumor redox status in head and neck cancer by 62Cu-ATSM PET.
    Tsujikawa T, Asahi S, Oh M, Sato Y, Narita N, Makino A, Kiyono Y, Tsuchida T, Kimura H, Fujieda S, Okazawa H.
    PLoS ONE 11(5) e0155635 May  2016 Refereed
    PURPOSE:Tumor redox is an important factor for cancer progression, resistance to treatments, and a poor prognosis. The aim of the present study was to define tumor redox (over-reduction) using 62Cu-diacetyl-bis(N4-methylthiosemicarbazone) (62Cu-ATSM) PET and compare its prognostic potential in head and neck cancer (HNC) with that of 2-deoxy-2-[18F]fluoro-D-glucose (18F-FDG).;METHODS:Thirty HNC patients (stage II-IV) underwent pretreatment 62Cu-ATSM and 18F-FDG PET scans. Maximum standardized uptake values (SUVATSM and SUVFDG) and tumor-to-muscle activity concentration ratios (TMRATSM and TMRFDG) were measured. Reductive-tumor-volume (RTV) was then determined at four thresholds (40%, 50%, 60%, and 70% SUVATSM), and total-lesion-reduction (TLR) was calculated as the product of the mean SUV and RTV for 62Cu-ATSM. In 18F-FDG, metabolic-tumor-volume (MTV) and total-lesion-glycolysis (TLG) were obtained at a threshold of 40%. A ROC analysis was performed to determine % thresholds for RTV and TLR showing the best predictive performance, and these were then used to determine the optimal cut-off values to stratify patients for each parameter. Progression-free-survival (PFS) and cause-specific-survival (CSS) were evaluated by the Kaplan-Meier method.;RESULTS:The means ± standard deviations of PFS and CSS periods were 16.4±13.4 and 19.2±12.4 months, respectively. A ROC analysis determined that the 70% SUVATSM threshold for RTV and TLR was the best for predicting disease progression and cancer death. Optimal cut-offs for each index were SUVATSM = 3.6, SUVFDG = 7.9, TMRATSM = 3.2, TMRFDG = 5.6, RTV = 2.9, MTV = 8.1, TLR = 14.0, and TLG = 36.5. When the cut-offs for TMRATSM and TLR were set as described above in 62Cu-ATSM PET, patients with higher TMRATSM (p = 0.03) and greater TLR (p = 0.02) showed significantly worse PFS, while patients with greater TLR had significantly worse CSS (p = 0.02). Only MTV in 18F-FDG PET predicted differences in PSF and CSS (p = 0.03 and p = 0.03, respectively).;CONCLUSION:Tumor redox parameters measured by 62Cu-ATSM PET may be determinants of HNC patient outcomes and help define optimal patient-specific treatments.
  • Increased oxidative stress is related to disease severity in the ALS motor cortex: A PET study
    M.Ikawa,H.Okazawa,T.Tsujikawa,A.Matsunaga,O.Yamamura,T.Mori,T.Hamano,Y,Kiyono,Y.Nakamoto,M.Yoneda
    Neurology 84(20) 2033-2039 May  2015 Refereed
  • Estimation of arterial input by a noninvasive image derived method in brain H215O PET study confirmation of arterial location using MR angiography
    Islam MM, Tsujikawa T, Mori T, Kiyono Y, Okazawa H
    Phys Med Biol 62(11) 4514-4524 Jun.  2017 Refereed
  • Precise evaluation of striatal oxidative stress corrected for severity of dopaminergic neuronal degeneration in patients with parkinson's disease: A study with 62Cu-ATSM PET and 123I-FP-CIT SPECT
    Neishi H, Ikawa M, Okazawa H, Tsujikawa T, Arishima H, Kikuta KI, Yoneda M
    Eur Neurol 78(3-4) 161-168 Aug.  2017 Refereed
  • Assessment of intratumor heterogeneity in mesenchymal uterine tumor by an (18)F-FDG PET/CT texture analysis
    Tsujikawa T, Yamamoto M, Shono K, Yamada S, Tsuyoshi H, Kiyono Y, Kimura H, Okazawa H, Yoshida Y
    Ann Nucl Med 31(10) 752-757 Sep.  2017 Refereed
  • A novel diagnostic strategy using 16α-[18F]-fluoro-17-β-estradiol (18F-FES) PET/MRI to achieve complete resection of intravenous leiomyomatosis in reproductive-age women
    Chino Y, Tsuyoshi H, Tsujikawa T, Okazawa H, Yoshida Y
    Clin Nucl Med 42(7) e335-e336 Jul.  2017 Refereed
  • 18F-FDG PET radiomics approaches: comparing and clustering features in cervical cancer
    Tsujikawa T, Rahman T, Yamamoto M, Yamada S, Tsuyoshi H, Kiyono Y, Kimura H, Yoshida Y, Okazawa H
    Ann Nucl Med 31(9) 678-685 Nov.  2017 Refereed
  • 18F-FDG/18F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma
    Yamamoto M, Tsujikawa T, Yamada S, Kurokawa T, Shinagawa A, Chino Y, Mori T, Kiyono Y, Okazawa H, Yoshida Y
    Oncotarget 8(14) 22581-22589 Apr.  2017 Refereed
    :We investigated whether 16α-[18F]-fluoro-17β-estradiol (18F-FES) and 18F-fluoro-deoxyglucose (FDG) uptake measured using positron emission tomography (PET) predicted prognosis in 18 patients with different histological subtypes of uterine sarcoma. Standardized uptake values (SUVs) and 18F-FDG/18F-FES SUV ratios were determined, and their correlations with progression-free (PFS) and overall survival (OS) were examined. Ten patients died from local recurrence or metastasis, and one more experienced recurrence, during the at least 36-month follow-up period. Patients with higher 18F-FDG SUVs (> 5.5) had worse OS (p = 0.007) and tended toward worse PFS (p = 0.11), while patients with lower 18F-FES SUVs (竕、 1.5) had worse PFS (p = 0.03) and tended toward worse OS (p = 0.19). Patients with 18F-FDG/18F-FES ratios > 2.6 had worse PFS (p = 0.009) and OS (p = 0.005). The 5-year PFS and OS rates were 75% and 88% for patients with lower ratios, but were only 10% and 20% for those with higher ratios. These results suggest that pretreatment tumor 18F-FDG/18F-FES ratio is useful for predicting the prognosis of uterine sarcoma patients.
  • Pixel-by-pixel precise delay correction for measurement of cerebral hemodynamic parameters in H2(15)O PET study
    Islam MM, Tsujikawa T, Mori T, Kiyono Y, Okazawa H
    Ann Nucl Med 31(4) 283-294 May  2017 Refereed
    OBJECTIVE:A new method of delay time estimation was proposed to measure precise cerebral blood flow (CBF) and arterial-to-capillary blood volume (V 0) using (15)O-water PET.;METHODS:Nineteen patients with unilateral arterial stenoocclusive lesions were studied to evaluate hemodynamic status before treatment. The delay time of each pixel was calculated using least squares fitting with an arterial blood input curve adjusted to the internal carotid artery counts at the skull base. Pixel-by-pixel delay estimation provided a delay map image that could be used for precise calculation of CBF and V 0 using a one-tissue compartment model, and the values from this method were compared with those from the slice-by-slice correction method.;RESULTS:The affected side showed a longer delay time than the contralateral cerebral hemisphere. Although the mean cortical CBF values were not different between the two methods, the slice-by-slice delay correction overestimatedツ?CBF in the hypo perfused area. The scatter plot of V 0 pixel values showed significant difference between the two correction methods where the slice-by-slice delay correction significantly overestimated V 0 in the whole brain (P窶?<窶?0.05).;CONCLUSION:Pixel-by-pixel delay correction provides delay images as well as better estimation of CBF and V 0, thus offering useful and beneficial information for the treatment of cerebrovascular disease.
  • [11C](R)-Rolipram positron emission tomography detects DISC1 inhibition of phosphodiesterase type 4 in live Disc1 locus-impaired mice
    Ooms M, Tsujikawa T, Lohith TG, Mabins SN, Zoghbi SS, Sumitomo A, Jaaro-Peled H, Kimura Y, Telu S, Pike VW, Tomoda T, Innis RB, Sawa A, Fujita M
    J Cereb Blood FlowMetab 2019 Refereed
  • Selected PET radiomic features remain the same
    Tsujikawa T, Tsuyoshi H, Kanno M, Yamada S, Kobayashi M, Narita N, Kimura H, Fujieda S, Yoshida Y, Okazawa H
    Oncotarget 9(29) 20734-20746 Apr.  2018 Refereed
  • Noninvasive method for measurement of cerebral blood flow using O-15 water PET/MRI with ASL correlation
    Okazawa H, Higashino Y, Tsujikawa T, Arishima H, Mori T, Kiyono Y, Kimura H, Kikuta K
    Eur J Radiol 105 102-109 Jun.  2018 Refereed
  • Role of PET/MRI in oral cavity and oropharyngeal cancers based on the 8th edition of the AJCC cancer staging system: a pictorial essay
    Tsujikawa T, Narita N, Kanno M, Takabayashi T, Fujieda S, Okazawa H
    Ann Nucl Med 32(4) 239-249 May  2018 Refereed
  • European research trends in nuclear medicine
    Inubushi M, Tatsumi M, Yamamoto Y, Kato K, Tsujikawa T, Nishii R
    Annals of Nuclear Medicine 32(9) 579-582 Nov.  2018 Refereed
  • Arterial spin labeling MR imaging for the clinical detection of cerebellar hypoperfusion in patients with spinocerebellar degeneration
    Ikawa M, Kimura H, Kitazaki Y, Sugimoto K, Matsunaga A, Hayashi K, Yamamura O, Tsujikawa T, Hamano T, Yoneda M, Okazawa H, Nakamoto Y
    Journal of the Neurological Sciences 394 58-62 Nov.  2018 Refereed
  • Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis
    Rahman MGM, Islam MM, Tsujikawa T, Kiyono Y, Okazawa H
    Ann Nucl Med 33(1) 14-21 Jan.  2019 Refereed
  • 18F-FLT PET/MRI for bone marrow failure syndrome-initial experience
    Tsujikawa T, Tasaki T, Hosono N, Mori T, Makino A, Kiyono Y, Zanotti-Fregonara P, Yamauchi T, Okazawa H
    Eur J Nucl Med Mol Img Re 9(1) 26 Feb.  2019 Refereed
  • No significant difference found in PET/MRI CBF values reconstructed with CT-atlas-based and ZTE MR attenuation correction
    Okazawa H, Tsujikawa T, Higashino Y, Kikuta K, Mori T, Makino A, Kiyono Y
    Eur J Nucl Med Mol Img Re 9(1) 26 Mar.  2019 Refereed
  • The vertebral 3'-deoxy-3'-18F-fluorothymidine uptake predicts the hematological toxicity after systemic chemotherapy in patients with lung cancer.
    Umeda Y, Tsujikawa T, Anzai M, Morikawa M, Waseda Y, Kadowaki M, Shigemi H, Ameshima S, Mori T, Kiyono Y, Okazawa H, Ishizuka T.
    Eur Radiol. 29(7) 3908-3917 Jul.  2019 Refereed
  • Whole-body bone marrow DWI correlates with age, anemia, and hematopoietic activity.
    Tsujikawa T, Oikawa H, Tasaki T, Hosono N, Tsuyoshi H, Yoshida Y, Yamauchi T, Kimura H, Okazawa H.
    Eur J Radiol. 118 223-230 Sep.  2019 Refereed
  • Predictive Value of 16α-[18F]-Fluoro-17β-Estradiol PET as a Biomarker of Progestin Therapy Resistance in Patients With Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer.
    Yamada S, Tsuyoshi H, Tsujikawa T, Okazawa H, Yoshida Y.
    Clin Nucl Med. 44(7) 574-575 Jul.  2019 Refereed

Conference Activities & Talks

  • Assessment of intratumor heterogeneity on FDG-PET/CT for differentiating between uterine sarcoma and leiomyoma
    Tsujikawa T, Yamamoto M, Chino Y, Shinagawa A, Tsuchida T, Kurokawa T, Yoshida Y, Okazawa H
    The 63th Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging Jun.  2016 Society of Nuclear Medicine
  • Functional images predict prognosis of uterine sarcoma patient: Estrogen receptor expression combined with FDG PET
    Tsujikawa T, Yamamoto M, Chino Y, Shinagawa A, Tsuchida T, Mori T, Kurokawa T, Kiyono Y, Yoshida Y, Okazawa H
    The 63th Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging Jun.  2016 Society of Nuclear Medicine
  • Assessment of hormone sensitivity in uterine leiomyoma patients using 18F-FES PET
    T.Tsujikawa, Y.Chino, A.Shinagawa, M.Yamamoto, A.Makino, T.Mori, T.Kurokawa, Y.Kiyono, Y.Yoshida, H.Okazawa
    SNMMI 2015 Annual Meeting
  • Cortical patterns and functional recovery in chronic stroke patients by functional electrical stimulation
    M.Kubota, O.Yamamura, T.Kamisawa, C.Igarashi, Y.Watabe, S.Shimada, T.Tsujikawa, H.Okazawa, R.Kato, H.Yokoi, K.Uchida, H.Baba
    American Society for Neurorehabilitation Annual Meeting 2014 Nov.  2014
  • Increased cerebral oxidative stress in amyotrophic lateral sclerosis: a 62Cu-ATSM PET study
    K.Miyazaki, M.Ikawa, T.Tsujikawa, T.Mori, T.Hamano, Y.Nakamoto, Y.Kiyono, H.Okazawa, M.Yoneda
    The 11th Conference of Asian Society for Mitochondrial Research and Medicine Nov.  2014
  • Hypoxic volume measurement using Cu-ATSM PET may be a predictive index for prognosis of advanced head-and-neck cancers: Comparison with FDG-PET.
    H.Okazawa, T.Tsujikawa, M.Oh, Y.Sato, T.Mori, S.Fujieda, Y.Kiyono
     Sep.  2014
  • Evaluation of cerebral oxidative stress in amyotrophic lateral sclerosis using 62Cu-ATSM PET.
    H.Okazawa, M.Ikawa, T.Tsujikawa, A.Matsunaga, T.Mori, Y.Kiyono, M.Yoneda
     Jun.  2014
  • Volume-based hypoxic parameters of 62Cu-ATSM PET as prognostic indicators in head and neck cancer
    T.Tsujikawa, S.Asahi, M. Oh, Y. Sato, T.Tsuchida, A. Makino, T.Mori, Y.Kiyono, S.Fujieda, H.Okazawa
    The 61st Annual Meeting of The Society of Nuclear Medicine Jun.  2014
  • Increased cerebral oxidative stress in amyotrophic lateral sclerosis: a 62Cu-ATSM PET study
    M.Ikawa, H.Okazawa, T.Tsujikawa, T.Muramatsu, T.Kishitani, T.Kamisawa, A.Matsunaga, O.Yamamura, T.Mori, T.Hamano, Y.Kiyono, Y.Nakamoto, M.Yoneda
    2014 AAN May  2014
  • Assessing tumor hypoxia in head and neck cancer by PET with 62Cu-ATSM
    辻川 哲也, 佐藤 義高, 呉 明美, 土田 龍郎, 藤枝 重治, 岡沢 秀彦
     Apr.  2014
  • PET Imaging of Estrogen Receptors in Metastatic Breast Cancer Patients
    H.Maeda, M.Nakazawa, T.Tsuchida, Y.Imamura, T.Mori, T.Tsujikawa, A.Yamaguchi, H.Okazawa
     Mar.  2014
  • Regional changes in cerebral oxidative stress of neurodegenerative disease evaluated by 62Cu-ATSM PET
    M.Yoneda, M. Ikawa, T.Tsujikawa, A.Matsunaga, T.Mori, Y.Kiyono, H.Okazawa
     Mar.  2014
  • Usefulness of total lesion glycolysis in FDG-PET studies for predicting the prognosis of ovarian cancer patients.
    M.Yamamoto, T.Kurokawa, Tetsuya Tsujikawa, Y.Kiyono, H.Okazawa, Y.Yoshida
     Mar.  2014
  • Regional changes in cerebral oxidative stress evaluated by 62Cu-ATSM PET in patients with amyotrophic lateral sclerosis.
    M.Yoneda, M. Ikawa, T.Tsujikawa, A.Matsunaga, T.Mori, Y.Kiyono, H.Okazawa
     Mar.  2014
  • The effect of functional electrical stimulation (FES) on H2[15O] PET in the post-stroke patients.
    T.Kamisawa, O.Yamamura, M.Kubota, C.Igarashi, Tetsuya Tsujikawa, K.Uchida, M.Suzuki, R.Kato, H.Yokoi, T. Hamano, Y.Nakamoto, H.Okazawa
     Mar.  2014
  • Usefulness of total lesion glycolysis in FDG-PET studies for predicting the prognosis of ovarian cancer patients
    M.Yamamoto, T.Kurokawa, T.Tsujikawa, Y.Kiyono, H.Okazawa, Y.Yoshida
    International Workshop on Molecular Functional Imaging for Brain and Gynecologic Oncology(Fukui2014) Mar.  2014
  • Crossedcellebellar diaschisis in clinically diagnosed corticobasal degeneration
    T.Hamano, A.Matsunaga, T.Muramatsu, T.Kishitani, S.Enomoto, K.Yamate, N.Shirafuji, M. Ikawa, T.Tsuchida, T.Tsujikawa, T.Kudo, H.Okazawa, M.Yoneda, M.Kuriyama, Y.Nakamoto
     Mar.  2014
  • Feasibility of pulsed continuous arterial spin labeling (pCASL) in quantitative evaluation of cerebral blood flow: Comparison with quantitative SPECT and PET
    M.Isozaki, A.Tada, Tetsuya Tsujikawa, H.Kimura, K.Kikuta, H.Okazawa
     Jan.  2014
  • PET imaging of cerebral oxidative stress in neurodegenerative disorders
    M.Yoneda, M.Ikawa, T.Tsujikawa, T.Mori, T.Hamano, Y.Nakamoto, Y.Kiyono, H.Okazawa
    5th World Congress on Targeting Mitochondria Jan.  2014
  • Metabotropic glutamate subtype 5 receptors are quantified in human brain with a novel ligand 11C-SP203
    T. Tsujikawa, CH. Yoo, Fabrice Simeon, Sami Zoghbi, Yi Zhang, Yasuyuki Kimura, Victor Pike, Robert Innis, Masahiro Fujita
    The 60th Annual Meeting of The Society of Nuclear Medicine Jun.  2013
  • Detection of presymptomatically latent lesions developing into stroke-like episodes by arterial spin-labeling perfusion MRI in MELAS patients
    M.Ikawa, H.Kimura, T.Muramatsu, A.Matsunaga, T.Tsujikawa, T.Yamamoto, N.Kosaka, K.Kinoshita, O.Yamamura, T.Hamano, Y.Nakamoto, M.Yoneda
     Mar.  2013
  • Quantification of human brain cannabinoid CB1 receptors using a novel PET radioligand, [11C]SD5024
    T.Tsujikawa, S. Zoghbi, J. Hong, S. Donohue, C. Halldin, V. Pike, R. Innis, M. Fujita
     Aug.  2012
  • Initial evaluation of [11C]SD5024, a novel PET radioligand for imaging human brain cannabinoid CB1 receptors
    T.Tsujikawa, S. Zoghbi, J. Hong, S. Donohue, C. Halldin, V. Pike, R. Innis, M. Fujita
     Jun.  2012
  • Additional diagnostic value of [F-18]-fluoroestradiol PET in patients with uterine smooth muscle tumors.
    Y.Yoshida, Y.Kiyono, T.Kurokawa, T.Tsujikawa, T.Mori, F.Kotsuji, H.Okazawa
     Jun.  2011
  • Assessment of the early response to chemotherapy with diffusion-weighted MRI in advanced lung cancer patients -comparison with FDG-PET-
    Tatsuro Tsuchida, Miwa Morikawa, Yoshiki Demura, Masato Sasaki, Tetsuya Tsujikawa, Hirohiko Kimura
    International Society of Magnetic Resonance Imaging in Medicine 2010 annual meeting May  2010
  • Pathophysiologic evaluation of stroke-like episodes in MELAS patients by MRI and PET
    M.Yoneda, M.Ikawa, T.Tsujikawa, K.Arakawa, T.Kudo, Y.Fujibayashi, H.Kimura, H.Okazawa, M.Kuriyama
    International Conference on Brain Function and Development Jan.  2010
  • Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images
    T.Tsujikawa, M.Yoneda, H.Uematsu, M.Toyooka, M.Ikawa, T.Kudo, H.Okazawa, M.Kuriyama, H.Kimura
    International Conference on Brain Function and Development Jan.  2010
  • Benefit of pixel-by-pixel delay correction for measurement of hemodynamic parameters in patients with cerebrovascular disease using O-15 PET
    H.Okazawa, T.Kudo, M.Kobayashi, M.Isozaki, Y.Arai, T.Tsujikawa, Y.Fujibayashi, T.Kubota
     Jul.  2009
  • Developement of steady-state method combining bolus and increscent injection with a multi-programming syinge pump.
    M.Kobayashi, Y.Michibata, R.Maruyama, Y.Higaki, Y.Kiyono, T.Kudo, T.Tsujikawa, Y.Yoshii, A.Waki, K.Kawai, Y.Fujibayashi, H.Okazawa
     Jul.  2009
  • hANP treatment on acute myocardial infarction patients improves myocardial perfusion of risked myocardium: Measured with N-13 ammonia PET
    T.Kudo, H.Uzui, J-D.Lee, M.Kobayashi, T.Tsujikawa, Y.Fujibayashi, H.Okazawa
    2009 SNM Annual Meeting Jun.  2009
  • Functional estrogen receptor alpha imaging PET with 16alpha-[18F]fluoro-17beta-estradiol in endometrial carcinoma
    T.Tsujikawa, Y.Yoshida, T.Kudo, T.Kurokawa, Y.Kiyono, Y.Fujibayashi, H.Okazawa
     Jun.  2009
  • Measurement of cerebral oxygen metabolism of rats using injectable O-15 oxygen and steady-state method.
    M.Kobayashi, V.N.Tiwari, R.Maruyama, Y.Kiyono, T.Kudo, T.Tsujikawa, K.Kawai, Y.Fujibayashi, H.Okazawa
     Jun.  2009
  • Functional estrogen receptor alpha imaging PET with 16alpha-[18F]fluoro-17beta-estradiol in endometrial carcinoma.
    辻川 哲也, 工藤 崇, 吉田 好雄, 清野 泰, 脇 厚生, 土田 龍郎, 藤林 康久, 岡沢 秀彦
     May  2009
  • Pathophysiologic evaluation of cerebral blood flow, energy status and oxidative stress during stroke-like episodes in MELAS patients by MRI and PET
    M.Yoneda, M.Ikawa, T.Tsujikawa, K.Arakawa, T.Kudo, Y.Fujibayashi, H.Kimura, H.Okazawa, M.Kuriyama
     Jan.  2009
  • Assessment of emission-based segmented attenuation correction method without transmission scan on small animal PET
    M.Kobayashi, Y.Higaki, T.Kudo, Y.Kiyono, T.Tsujikawa, Y.Yoshii, Y.Michibata, K.Sakai, M.Watanabe, K.Kawai, Y.Fujibayashi, H.Okazawa
    2008 Worl Molecular Imaging Congress Sep.  2008
  • 16alpha-[18F]fluoro-17beta-estradiol PET is useful for non-invasive estrogen receptor alpha imaging in endometrial carcinoma
    T.Tsujikawa, T.Kudo, Y.Yoshida, Y.Kiyono, M.Kobayashi, Y.Fujibayashi, H.Okazawa
    2008 Worl Molecular Imaging Congress Sep.  2008
  • Comparison of distribution of FDG and Cu-62 ATSM in head and neck cancer
    T.Kudo, T.Tsujikawa, M.Kobayashi, T.Tsuchida, M.Oh, S.Fujieda, T.Saga, H.Okazawa, Y.Fujibayashi
    The 55th annual meeting of society of nuclear medicine Jun.  2008
  • C-11 acetate washout in mitochondrial cardiomyopathy: Uncoupling between acetate washout and metabolism
    T.Kudo, T.Tsujikawa, M.Kobayashi, K.Arakawa, M.Ikawa, M.Yoneda, I.Miyamori, M.Kuriyama, Y.Fujibayashi, H.Okazawa
    The 55th Annual Meeting of Society of Nuclear Medicine Jun.  2008
  • Emission segmented attenuation correction method without transmission scan can accurately measure tracer concentration on small animal PET.
    M.Kobayashi, T.Kudo, Y.Kiyono, T.Tsujikawa, M.Watanabe, H.Okazawa, Y.Fujibayashi
    The 55th SNM Annual Meeting Jun.  2008
  • Effect of transmission protocol on statistical analysis of brain 18F-FDG PET; Comparison between pre- and post-injection transmission scans.
    M.Kobayashi, T.Kudo, T.Tsujikawa, Y.Kiyono, Y.Fujibayashi, H.Okazawa
    Human Brain Mapping 2008 Jun.  2008
  • FES and FDG-PET imaging reflects clinical and histopathological findings in patients with endometrial carcinoma
    T.Tsujikawa, T.Kudo, Y.Yoshida, Y.Kiyono, M.Kobayashi, T.Tsuchida, Y.Fujibayashi, H.Okazawa
     Jun.  2008
  • Effect of intravenous adenosine-tri-phosphate (ATP) on cerebral blood flow by bolus 15O-labeled water PET study on human volunteers.
    R.Hussain, T.Tsuchida, T.Kudo, T.Tsujikawa, M.Kobayashi, Y.Fujibayashi, H.Okazawa
    The 55th SNM Annual Meeting Jun.  2008
  • Histological differentiation of lung cancer with 3-point imaging of FDG-PET
    T.Tsuchida, Y.Demura, H.Okazawa, T.Tsujikawa, T.Kudoh, H.Kimura
    The 55th annual meeting of society of nuclear medicine Jun.  2008
  • C11-acetate washout in mitochondrial cardiomyoopathy: Uncoupling between acetate washout and metabolism
    T.Kudo, T.Tsujikawa, M.Kobayasi, K.Arakawa, M.Ikawa, M.Yoneda, I.Miyamori, M.Kuriyama, Y.Fujibayashi, H.Okazawa
     Jun.  2008
  • Role of intravenous Adenosine-tri-phosphate(ATP) on human cerebral blood flow: assessed by bolus 15O-labeled water PET study
    R.Hussain, T.Tsuchida, T.Kudo, T.Tsujikawa, M.Kobayashi, Y.Fujibayashi, H.Okazawa
     May  2008
  • Accumulation of 62Cu- ATSM is different from that of 18F- FDG in head and neck cancer
    M.Oh, T.Kudo, T.Tsujikawa, M.Kobayashi, H.Okazawa, Y.Fujibayashi, S.Fujieda
     Apr.  2008
  • Estimation of noninvasive arterial input in brain O-15 water PET study
    Islam MM, Tsujikawa T, Mori T, Kiyono Y, Okazawa H
    The 56th Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Nov.  2016 The Japanese Society of Nuclear Medicine
  • Effect of intravenous adenosine-tri-phosphate (ATP) on cerebral blood flow by bolus 15O-labeled water PET study
    R.Hussain, T.Tsuchida, T.Kudo, T.Tsujikawa, M.Kobayashi, Y.Fujibayashi, H.Okazawa
    The 13th National Conderence of Society of Nuclear Medicine, Bangladesh Feb.  2008
  • Evaluation of quantitative accuracy using the transmissionless-based emission segmented attenuation correction method in small animal PET
    M.Kobayashi, H.Okazawa, M.Oh, T.Tsujikawa, T.Mori, K.Sakai, M.Watanabe, Y.Kiyono, T.Kudo, K.Kawai, Y.Fujibayashi
     Sep.  2007
  • Potential of shorter examination time for diagnosis of misery perfusion using count-based OEF increase in O-15 gas PET.
    M.Kobayashi, H.Okazawa, T.Tsujikawa, T.Tsuchida, M.Isozaki, Y.Arai, K.Kawai, Y.Fujibayashi
    The 54th Annual Meeting of the Society of Nuclear Medicine Jun.  2007
  • Differential diagnosis of endometrial hyperplasia and cancer using combined 18F-FES and 18F-FDG PET
    T.Tsujikawa, H.Okazawa, Y.Yoshida, T.Mori, K.Kobayashi, T.Tsuchida, Y.Fujibayashi
    The 54th Annual Meeting of the Society of Nuclear Medicine Jun.  2007
  • Importance of baseline CBF evaluation for detection of critical hemodynamic status in cerebrovascular disease: Comparison with acetazolamide test using PET.
    H.Okazawa, T.Tsujikawa, Y.Arai, M.Kobayashi, M.Isozaki, Y.Fujibayashi
    The 23rd International Symposium on Cerebral Blood Flow, Metabolism and Function (Brain 07) May  2007
  • Accurate delay correction for quantitative measurement of cerebral blood flow and arterial-to-capillary blood volume (V0).
    H.Okazawa, T.Tsujikawa, M.Kobayashi, M.Isozaki, Y.Arai
    The 8th International Conference on Quantification of Brain Function with PET May  2007
  • Possibility of scan time reduction for count-based OEF elevation in O-15 gas PET.
    M.Kobayashi, H.Okazawa, T.Tsujikawa, T.Tsuchida, M.Isozaki, Y.Arai, K.Kawai, Y.Fujibayashi
    The 8th International Conference on Quantification of Brain Function with PET May  2007
  • Feasibility of F-18 FES-PET for gynecological tumors
    T.Tsujikawa, H.Okazawa, Y.Yoshida, T.Mori, T.Tsuchida, T.Kurokawa, M.Kobayashi, Y.Fujibayashi
     Sep.  2006
  • Evaluation of the count recovery coefficient of a whole-body PET/CT scanner in 3D mode image
    T. Tsujikawa, H.Okazawa, H. Otsuka, N. Morita, H. Nishitani
    Annual Congress of the European Association of Nuclear Medicine Sep.  2006
  • Evaluation of gynecological tumors and endometriosis using [F-18]-fluoroestradiol and PET
    H.Okazawa, Y.Yoshida, T.Mori, T.Tsuchida, T.Kurokawa, M.Kobayashi, T.Tsujikawa, Y.Yonekura, Y.Fujibayashi
    Annual Congress of the European Association of Nuclear Medicine Sep.  2006
  • How accurately can reductions in baseline CBF and vasoreactivity detect misery perfusion in cerebrovascular disease?
    H.Okazawa, T.Tsuchida, Y.Arai, M.Kobayashi, T.Mori, T.Tsujikawa, Y.Yonekura, Y.Fujibayashi
    Annual Congress of the European Association of Nuclear Medicine Sep.  2006
  • Diagnosis of misery perfusion using noninvasive 15O-gas PET
    M.Kobayashi, H.Okazawa, T.Tsuchida, K.Kawai, T.Mori, T.Tsujikawa, Y.Yonekura, Y.Fujibayashi
    Annual Congress of the European Association of Nuclear Medicine Sep.  2006
  • Intensity of [F-18] fluorodeoxyglucose uptake in PET/CT correlates the clinical aggressiveness of malignant lymphoma
    T.Tsujikawa, H.Otsuka, H.Okazawa, Y.Fujibayashi, H.Nishitani
    The 9th Congress of World Federation of Nuclear Medicine & Biology Jan.  2006
  • Evaluation of gynecological tumors and endometriosis using F-18 fluoroestradiol and PET
    H.Okazawa, Y.Yoshida, T.Tsujikawa, T.Mori, T.Tsuchida, M.Kobayashi, Y.Fujibayashi
    The 9th Congress of World Federation of Nuclear Medicine & Biology Jan.  2006
  • Assessment of noninvasive examination method for diagnosis of misery perfusion in [O-15] oxygen-gas PET
    M.Kobayashi, H.Okazawa, T.Tsuchida, T.Tsujikawa, M.Isozaki, Y.Arai, K.Kawai, Y.Fujibayashi
    The 9th Congress of World Federation of Nuclear Medicine & Biology Jan.  2006
  • Evaluation of nigrostriatal oxidative stress intensity in patients with Parkinson’s disease using [Cu-62]ATSM PET and FP-CIT SPECT.
    H.Okazawa, M.Ikawa, T.Tsujikawa , T.Mori, A.Makino, Y.Kiyono, M.Yoneda
    Annual Congress of the European Association of Nuclear Medicine (EANM2015)  Oct.  2015
  • Evaluation of Striatal oxidative stress in Parkinson’s disease using [Cu-62]ATSM PET.
    H.Okazawa, M.Ikawa, T.Tsujikawa, T.Mori, Y.Kiyono, M.Yoneda
    Brain & Brain PET 2015 (XXVIIth International Symposium on Cerebral Blood Flow, Metabolism and Function) Jun.  2015
  • Prediction of head and neck cancer outcome evaluated by tumor redox status using 62Cu-ATSM PET.
    T.Tsujikawa, S.Asahi, M.Oh, T.Mori, Y.Kiyono, H.Okazawa
    The 62th Annual Meeting of The Society of Nuclear Medicine Jun.  2015
  • Hypoxic intensity and tumor burden measured by 62Cu-ATSM-PET in head and neck cancer patients: Comparison of prognostic prediction with FDG-PET
    T.Tsujikawa, S.Asahi, M.Oh, Y.Sato, T.Mori, Y.Kiyono, S.Fujieda, H.Kimura, H.Okazawa
    第74回日本医学放射線学会学術集会 Apr.  2015
  • PET Imaging of Estrogen Receptors in Metastatic Breast Cancer
    Maeda H, Higashi M, Tsuchida T, Mori T,Tsujikawa T, Imamura Y, Okazawa H, Goi T
     Oct.  2016
  • Clinical benefits of precise delay correction for CBF measurement in O-15 water PET study.
    Islam MM, Tsujikawa T, Mori T, Kiyono Y, Okazawa H.
    The 63th Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging Jun.  2016 Society of Nuclear Medicine
  • Prognostic value of FES PET in patients with endometrial cancer
    Tsujikawa T, Yamada S, Tsuyoshi H, Kurokawa T, Shinagawa A, Chino Y, Mori T, Makino A, Kiyono Y, Yoshida Y
     May  2017
  • 18F-FES and 18F-FDG PET/MR imaging of gynecologic tumors:Initial experience in 5 cases
    Tsujikawa T, Tsuyoshi H, Yamada S, Shinagawa A, Chino Y, Mori T, Kurokawa T, Kiyono Y, Yoshio Y, Okazawa H
    The 64th Annual Meeting of The Society of Nuclear Medicine Jun.  2017
  • Impact of scan duration on textural features in 18F-FDG PET/MR
    Tsujikawa T, Kobayashi M, Tsuyoshi H, Yamada S, Oikawa H, Yoshida Y, Okazawa H
     Oct.  2017
  • Dopaminergic neuronal oxidative stress is increased with disease severity in patients with Parkinson's disease: A study with PET and SPECT
    Ikawa M, Okazawa H, Neishi H, Kitazaki Y, Tsujikawa T, Kikuta K, Nakamoto Y, Yoneda M
    28th International Symposium on Cerebral Blood Flow. Metabolism and Function and 13th Conference on Quantification of Brain Function with PET Apr.  2017
  • PET neuroimaging for oxidative stress based on mitochondrial dysfunction in neurodegenerative diseases
    Ikawa M, Okazawa H, Tsujikawa T, Nakamoto Y, Yoneda M
    World Congress of Neurology Sep.  2017
  • Molecular brain imaging evaluates the pathophysiology of stroke-like episodes in MELAS
    Yoneda M, Ikawa M, Tsujikawa T, Kimura H, Okazawa H
    World Congress of Neurology Sep.  2017
  • Measurement of cerebral blood flow with H215O PET/MRI.
    Okazawa H, Tsujikawa T, Higashino Y, Arishima H, Mori T, Kiyono Y, Kikuta K.
    Brain & Brain PET 2017 Apr.  2017
  • Measurement of cerebral blood flow using H215O PET/MRI with a noninvasive method.
    Okazawa H, Higashino Y, Tsujikawa T, Mori T, Arishima H, Kiyono Y, Kikuta K.
    The 64th Annual Meeting of The Society of Nuclear Medicine Jun.  2017
  • Dopaminergic neuronal oxidative stress is increased with disease progression in patients with Parkinson’s disease: A study with PET and SPECT
    Ikawa M, Okazawa H, Neishi H, Kitazaki Y, Tsujikawa T, Kikuta K, Nakamoto Y, Yoneda M
    Annual Meeting of American Academy of Neurology Apr.  2017
  • Assessment of intratumor heterogeneity in mesenchymal uterine tumor by FDG-PET/CT texture analysis.
    Tsujikawa T, Yamamoto M, Shono K, Yamada S, Kimura H, Okazawa H, Yoshida Y
     Apr.  2017
  • 分子イメージングによるMELAS脳卒中様発作の病態解明
    井川 正道, 岡沢 秀彦, 辻川 哲也, 清野 智恵子, 前田 浩幸, 川谷 正男, 畑 郁江, 木村 浩彦, 和田 有司, 米田 誠
    第36回北陸臨床遺伝研究会 Feb.  2016
  • Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis
    Rahman M, Islam M, Tsujikawa T, Sugimoto K, Okazawa H
    The 12th World Congress of the World Federation of Nuclear Medicine and Biology (WFNMB 2018) Apr.  2018 World Federation of Nuclear Medicine and Biology
  • A new method for [123I]FP-CIT specific binding ratio estimation in evaluation of striatal function
    Rahman M, Islam M, Tsujikawa T, Kiyono Y, Okazawa H
    The 65th Annual Meeting of The Society of Nuclear Medicine Jun.  2018 Society of Nuclear Medicine
  • Selected PET radiomic features remain the same - Clinical validation with PET/CT & PET/MRI -
    Tsujikawa T, Tsuyoshi H, Kannno M, Yamada S, Kobayashi M, Narita N, Kimura H, Fujieda S, Yoshida Y, Okazawa H
    The 77th Annual Meeting of the Japan Radiological Society Apr.  2018
  • Role of PET/MRI in oral cavity and oropharyngeal cancer based on the 8th edition of the AJCC cancer staging system
    Tsujikawa T, Narita N, Kannno M, Takabayashi T, Fujieda S, Okazawa H
    The 12th World Congress of the World Federation of Nuclear Medicine and Biology (WFNMB 2018) Apr.  2018 World Federation of Nuclear Medicine and Biology
  • Integrated FDG-PET/MRI enhances the diagnostic ability for distinguishing between type I and II endometrial cancers
    Tsujikawa T, Tsuyoshi H, Yamada S, Shinagawa A, Chino Y, Kurokawa T, Yoshida Y, Okazawa H
    The 65th Annual Meeting of The Society of Nuclear Medicine Jun.  2018 Society of Nuclear Medicine
  • PET/MRI
    Tsujikawa T
    IAEA regional workshop on understanding CT scan-Role in hybrid imaging (PET/CT and SPECT/CT) Oct.  2018 IAEA
  • Assessment of bone marrow proliferation in bone marrow failure syndrome by FLT-PET/MRI
     Nov.  2018